Hypopharyngeal cancer medical therapy

Hypopharyngeal cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hypopharyngeal Cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiogram or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hypopharyngeal cancer medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hypopharyngeal cancer medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hypopharyngeal cancer medical therapy
CDC on Hypopharyngeal cancer medical therapy
Hypopharyngeal cancer medical therapy in the news
Blogs on Hypopharyngeal cancer medical therapy
Directions to Hospitals Treating Hypopharyngeal cancer
Risk calculators and risk factors for Hypopharyngeal cancer medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]

Overview

The optimal therapy for hypopharyngeal cancer depends on the stage at the time of diagnosis.

Medical Therapy

The optimal therapy for hypopharyngeal cancer depends on the stage at the time of diagnosis. Treatment according to stages is as follows:

Stage	Treatment
Stage 1	Laryngopharyngectomy and neck dissection with or without high-dose radiation therapy to the lymph nodes of the neck Partial laryngopharyngectomy with or without high-dose radiation therapy to the lymph nodes on both sides of the neck
Stage 2	Laryngopharyngectomy and neck dissection High-dose radiationtherapy to the lymph nodes of the neck may be given before or after surgery Chemotherapy given during or after radiation therapy or after surgery
Stage 3	Radiation therapy before or after surgery Chemotherapy given during or after radiation therapy or after surgery Radiation therapy followed by surgery to remove cancer containing lymph nodes in the neck that remain or come back after radiation therapy If all or part of the hypopharynx is removed, the patient may need reconstructive surgery
Stage 4	Chemotherapy given with radiation therapy Radiation therapy Radiation therapy followed by surgery to remove cancer containing lymph nodes in the neck that remain or come back after radiation therapy Chemotherapy for cancer that has metastasized (spread) to other parts of the body Treatment of stage IV hypopharyngeal cancer that cannot be treated with surgery may include: Chemotherapy given at the same time as radiation therapy The goal of treatment is to completely remove the cancer and prevent it from metastasizing to other parts of the body When the tumor is larger or has spread to lymph nodes in the neck, a combination of radiation and chemotherapy is often used to preserve the larynx

Supportive Treatment

Many patients also need swallowing therapy after treatment to help them adjust to the changes in the structure of the throat.

Radiation Therapy

• Radiation therapy is used as a single modality treatment in early lesions.
• Laser surgery is tending to replace radiotherapy for these lesions as the outcomes are similar and the treatment involves only a 1 or 2 days hospital stay.
• In certain advanced hypopharyngeal and laryngeal cancer, where combined radiotherapy and chemotherapy offers organ preservation and good locoregional control without surgery.
• For palliation for recurrent disease or advanced disease not suitable for surgery or organ preservation through chemoradiotherapy.
• Radiation is delivered by external beam in dedicated radiotherapy units.
• Radiation affects both normal tissue and cancer tissue, and the salivary glands and oral mucosa are particularly affected.
• Dryness is a common post-radiotherapy complaint.
• The mandible is commonly devascularised following radiotherapy and very prone to osteomyelitis and necrosis, secondary to dental sepsis.